Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials–Process Perspective

Abstract

Three dimensional (3D) printing as an advanced manufacturing technology is progressing to be established in the pharmaceutical industry to overcome the traditional manufacturing regime of 'one size fits for all'. Using 3D printing, it is possible to design and develop complex dosage forms that can be suitable for tuning drug release. Polymers are the key materials that are necessary for 3D printing. Among all 3D printing processes, extrusion-based (both fused deposition modeling (FDM) and pressure-assisted microsyringe (PAM)) 3D printing is well researched for pharmaceutical manufacturing. It is important to understand which polymers are suitable for extrusion-based 3D printing of pharmaceuticals and how their properties, as well as the behavior of polymer–active pharmaceutical ingredient (API) combinations, impact the printing process. Especially, understanding the rheology of the polymer and API–polymer mixtures is necessary for successful 3D printing of dosage forms or printed structures. This review has summarized a holistic materials–process perspective for polymers on extrusion-based 3D printing. The main focus herein will be both FDM and PAM 3D printing processes. It elaborates the discussion on the comparison of 3D printing with the traditional direct compression process, the necessity of rheology, and the characterization techniques required for the printed structure, drug, and excipients. The current technological challenges, regulatory aspects, and the direction toward which the technology is moving, especially for personalized pharmaceuticals and multi-drug printing, are also briefly discussed.

References 182

1. 1.

   Ligon S.C., Liska R., Stampfl J., Gurr M., Mülhaupt R. Polymers for 3D printing and customized additive manufacturing. Chem. Rev. 2017;117:10212-10290.

   Not in our library10.1021/acs.chemrev.7b00074

2. 2.

   Hofmann M. 3D printing gets a boost and opportunities with polymer materials. ACS Macro Lett. 2014;3:382-386.

   Not in our library10.1021/mz4006556

3. 3.

   Vikram Singh A., Hasan Dad Ansari M., Wang S., Laux P., Luch A., Kumar A., Patil R., Nussberger S. The Adoption of Three-Dimensional Additive Manufacturing from Biomedical Material Design to 3D Organ Printing. Appl. Sci. 2019;9:811.

   Not in our library10.3390/app9040811

4. 4.

   Norman J., Madurawe R.D., Moore C.M., Khan M.A., Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv. Drug Deliv. Rev. 2017;108:39-50.

   Not in our library10.1016/j.addr.2016.03.001

5. 5.

   Liaw C.-Y., Guvendiren M. Current and emerging applications of 3D printing in medicine. Biofabrication. 2017;9:024102.

   Not in our library10.1088/1758-5090/aa7279

6. 6.

   Yoo J., Bradbury T.J., Bebb T.J., Iskra J., Surprenant H.L., West T.G. Three-Dimensional Printing System and Equipment Assembly. U.S. Patent. 2014.

   Not in our library

7. 7.

   Ginsburg G.S., McCarthy J.J. Personalized medicine: Revolutionizing drug discovery and patient care. Trends Biotechnol. 2001;19:491-496.

   Not in our library10.1016/s0167-7799(01)01814-5

8. 8.

   Schork N.J. Personalized medicine: Time for one-person trials. Nature. 2015;520:609-611.

   Not in our library10.1038/520609a

9. 9.

   Yu D.G., Zhu L.-M., Branford-White C.J., Yang X.L. Three-Dimensional Printing in Pharmaceutics: Promises and Problems. J. Pharm. Sci. 2008;97:3666-3690.

   Not in our library10.1002/jps.21284

10. 10.

    Sachs E., Cima M., Williams P., Brancazio D., Cornie J. Three dimensional printing: Rapid tooling and prototypes directly from a CAD model. J. Manuf. Sci. Eng. 1992;114:481-488.

    Not in our library10.1115/1.2900701

11. 11.

    Goole J., Amighi K. 3D printing in pharmaceutics: A new tool for designing customized drug delivery systems. Int. J. Pharm. 2016;499:376-394.

    Not in our library10.1016/j.ijpharm.2015.12.071

12. 12.

    Wu B.M., Borland S.W., Giordano R.A., Cima L.G., Sachs E.M., Cima M.J. Solid free-form fabrication of drug delivery devices. J. Control. Release. 1996;40:77-87.

    Not in our library10.1016/0168-3659(95)00173-5

13. 13.

    Rowe C., Katstra W., Palazzolo R., Giritlioglu B., Teung P., Cima M. Multimechanism oral dosage forms fabricated by three dimensional printing™. J. Control. Release. 2000;66:11-17.

    Not in our library10.1016/s0168-3659(99)00224-2

14. 14.

    Wang C.-C., Tejwani M.R., Roach W.J., Kay J.L., Yoo J., Surprenant H.L., Monkhouse D.C., Pryor T.J. Development of near zero-order release dosage forms using three-dimensional printing (3-DP™) technology. Drug Dev. Ind. Pharm. 2006;32:367-376.

    Not in our library10.1080/03639040500519300

15. 15.

    Yu D.G., Yang X.L., Huang W.D., Liu J., Wang Y.G., Xu H. Tablets with material gradients fabricated by three-dimensional printing. J. Pharm. Sci. 2007;96:2446-2456.

    Not in our library10.1002/jps.20864

16. 16.

    Infanger S., Haemmerli A., Iliev S., Baier A., Stoyanov E., Quodbach J. Powder bed 3D-printing of highly loaded drug delivery devices with hydroxypropyl cellulose as solid binder. Int. J. Pharm. 2019;555:198-206.

    Not in our library10.1016/j.ijpharm.2018.11.048

17. 17.

    Khaled S.A., Burley J.C., Alexander M.R., Roberts C.J. Desktop 3D printing of controlled release pharmaceutical bilayer tablets. Int. J. Pharm. 2014;461:105-111.

    Not in our library10.1016/j.ijpharm.2013.11.021

18. 18.

    Khaled S.A., Burley J.C., Alexander M.R., Yang J., Roberts C.J. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. J. Control. Release. 2015;217:308-314.

    Not in our library10.1016/j.jconrel.2015.09.028

19. 19.

    Goyanes A., Buanz A.B., Hatton G.B., Gaisford S., Basit A.W. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Eur. J. Pharm. Biopharm. 2015;89:157-162.

    Not in our library10.1016/j.ejpb.2014.12.003

20. 20.

    Pietrzak K., Isreb A., Alhnan M.A. A flexible-dose dispenser for immediate and extended release 3D printed tablets. Eur. J. Pharm. Biopharm. 2015;96:380-387.

    Not in our library10.1016/j.ejpb.2015.07.027

21. 21.

    Chen D., Xu X.-Y., Li R., Zang G.-A., Zhang Y., Wang M.-R., Xiong M.-F., Xu J.-R., Wang T., Fu H., et al. Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages. AAPS PharmSciTech. 2020;21:6.

    Not in our library10.1208/s12249-019-1521-x

22. 22.

    Alhijjaj M., Nasereddin J., Belton P., Qi S. Impact of Processing Parameters on the Quality of Pharmaceutical Solid Dosage Forms Produced by Fused Deposition Modeling (FDM). Pharmaceutics. 2019;11:633.

    Not in our library10.3390/pharmaceutics11120633

23. 23.

    Eleftheriadis G.K., Ritzoulis C., Bouropoulos N., Tzetzis D., Andreadis D.A., Boetker J., Rantanen J., Fatouros D.G. Unidirectional drug release from 3D printed mucoadhesive buccal films using FDM technology: In vitro and ex vivo evaluation. Eur. J. Pharm. Biopharm. 2019;144:180-192.

    Not in our library10.1016/j.ejpb.2019.09.018

24. 24.

    Viidik L., Seera D., Antikainen O., Kogermann K., Heinämäki J., Laidmäe I. 3D-printability of aqueous poly(ethylene oxide) gels. Eur. Polym. J. 2019;120:109206.

    Not in our library10.1016/j.eurpolymj.2019.08.033

25. 25.

    Feuerbach T., Callau-Mendoza S., Thommes M. Development of filaments for fused deposition modeling 3D printing with medical grade poly(lactic-co-glycolic acid) copolymers. Pharm. Dev. Technol. 2018;24:487-493.

    Not in our library10.1080/10837450.2018.1514522

26. 26.

    Nukala P.K., Palekar S., Patki M., Patel K. Abuse Deterrent Immediate Release Egg-Shaped Tablet (Egglets) Using 3D Printing Technology: Quality by Design to Optimize Drug Release and Extraction. AAPS PharmSciTech. 2019;20:80.

    Not in our library10.1208/s12249-019-1298-y

27. 27.

    Healy A.V., Fuenmayor E., Doran P., Geever L.M., Higginbotham C.L., Lyons J.G. Additive Manufacturing of Personalized Pharmaceutical Dosage Forms via Stereolithography. Pharmaceutics. 2019;11:645.

    Not in our library10.3390/pharmaceutics11120645

28. 28.

    Martinez P.R., Goyanes A., Basit A.W., Gaisford S. Influence of Geometry on the Drug Release Profiles of Stereolithographic (SLA) 3D-Printed Tablets. AAPS PharmSciTech. 2018;19:3355-3361.

    Not in our library10.1208/s12249-018-1075-3

29. 29.

    Wang J., Goyanes A., Gaisford S., Basit A.W. Stereolithographic (SLA) 3D printing of oral modified-release dosage forms. Int. J. Pharm. 2016;503:207-212.

    Not in our library10.1016/j.ijpharm.2016.03.016

30. 30.
    3D Printed Pellets (Miniprintlets): A Novel, Multi-Drug, Controlled Release Platform Technology · 2019

    No notice
31. 31.

    Fina F., Madla C.M., Goyanes A., Zhang J., Gaisford S., Basit A.W. Fabricating 3D printed orally disintegrating printlets using selective laser sintering. Int. J. Pharm. 2018;541:101-107.

    Not in our library10.1016/j.ijpharm.2018.02.015

32. 32.

    Fina F., Goyanes A., Gaisford S., Basit A.W. Selective laser sintering (SLS) 3D printing of medicines. Int. J. Pharm. 2017;529:285-293.

    Not in our library10.1016/j.ijpharm.2017.06.082

33. 33.

    Kyobula M., Adedeji A., Alexander M.R., Saleh E., Wildman R., Ashcroft I., Gellert P.R., Roberts C.J. 3D inkjet printing of tablets exploiting bespoke complex geometries for controlled and tuneable drug release. J. Control. Release. 2017;261:207-215.

    Not in our library10.1016/j.jconrel.2017.06.025

34. 34.

    Clark E.A., Alexander M.R., Irvine D.J., Roberts C.J., Wallace M.J., Sharpe S., Yoo J., Hague R.J.M., Tuck C.J., Wildman R.D. 3D printing of tablets using inkjet with UV photoinitiation. Int. J. Pharm. 2017;529:523-530.

    Not in our library10.1016/j.ijpharm.2017.06.085

35. 35.

    Cader H.K., Rance G.A., Alexander M.R., Gonçalves A.D., Roberts C.J., Tuck C.J., Wildman R.D. Water-based 3D inkjet printing of an oral pharmaceutical dosage form. Int. J. Pharm. 2019;564:359-368.

    Not in our library10.1016/j.ijpharm.2019.04.026

36. 36.

    Kadry H., Wadnap S., Xu C., Ahsan F. Digital light processing (DLP) 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets. Eur. J. Pharm. Sci. 2019;135:60-67.

    Not in our library10.1016/j.ejps.2019.05.008

37. 37.

    Krkobabić M., Medarević D., Cvijić S., Grujić B., Ibrić S. Hydrophilic excipients in digital light processing (DLP) printing of sustained release tablets: Impact on internal structure and drug dissolution rate. Int. J. Pharm. 2019;572:118790.

    Not in our library10.1016/j.ijpharm.2019.118790

38. 38.

    Goyanes A., Buanz A.B., Basit A.W., Gaisford S. Fused-filament 3D printing (3DP) for fabrication of tablets. Int. J. Pharm. 2014;476:88-92.

    Not in our library10.1016/j.ijpharm.2014.09.044

39. 39.

    Godwin A., Bolina K., Clochard M., Dinand E., Rankin S., Simic S., Brocchini S. New strategies for polymer development in pharmaceutical science—A short review. J. Pharm. Pharmacol. 2001;53:1175-1184.

    Not in our library10.1211/0022357011776612

40. 40.

    Jones D.S. Pharmaceutical Applications of Polymers for Drug Delivery. 2004.

    Not in our library

41. 41.

    Park B.J., Choi H.J., Moon S.J., Kim S.J., Bajracharya R., Min J.Y., Han H.-K. Pharmaceutical applications of 3D printing technology: Current understanding and future perspectives. J. Pharm. Investig. 2019;49:575-585.

    Not in our library10.1007/s40005-018-00414-y

42. 42.

    Souto E.B., Campos J.C., Filho S.C., Teixeira M.C., Martins-Gomes C., Zielinska A., Carbone C., Silva A.M. 3D printing in the design of pharmaceutical dosage forms. Pharm. Dev. Technol. 2019;24:1044-1053.

    Not in our library10.1080/10837450.2019.1630426

43. 43.
    The Digital Pharmacies Era: How 3D Printing Technology Using Fused Deposition Modeling Can Become a Reality · 2019

    Not checked
44. 44.
    Advanced Pharmaceutical Applications of Hot-Melt Extrusion Coupled with Fused Deposition Modelling (FDM) 3D Printing for Personalised Drug Delivery · 2018

    No notice
45. 45.
    Application of Micro-Scale 3D Printing in Pharmaceutics · 2019

    Not checked
46. 46.

    Gioumouxouzis C.I., Karavasili C., Fatouros D.G. Recent advances in pharmaceutical dosage forms and devices using additive manufacturing technologies. Drug Discov. Today. 2019;24:636-643.

    Not in our library10.1016/j.drudis.2018.11.019

47. 47.
    The Role of 3D Printing in Medical Applications: A State of the Art · 2019

    No notice
48. 48.

    Vithani K., Goyanes A., Jannin V., Basit A.W., Gaisford S., Boyd B.J. An Overview of 3D Printing Technologies for Soft Materials and Potential Opportunities for Lipid-based Drug Delivery Systems. Pharm. Res. 2019;36:4.

    Not in our library10.1007/s11095-018-2531-1

49. 49.

    Joo Y., Shin I., Ham G., Abuzar S.M., Hyun S.-M., Hwang S.-J. The advent of a novel manufacturing technology in pharmaceutics: Superiority of fused deposition modeling 3D printer. J. Pharm. Investig. 2019;1-15.

    Not in our library10.1007/s40005-019-00451-1

50. 50.

    Long J., Gholizadeh H., Lu J., Bunt C., Seyfoddin A. Application of fused deposition modelling (FDM) method of 3D printing in drug delivery. Cur. Pharm. Des. 2017;23:433-439.

    Not in our library10.2174/1381612822666161026162707

51. 51.

    He D., Han F., Wang Z., Liu Q. A review of 3D printing via fused deposition modeling in pharmaceutics. Acta Pharm. Sin. 2016;51:1659-1665.

    Not in our library

52. 52.
    Personalised 3D Printed Medicines: Which Techniques and Polymers Are More Successful? · 2017

    No notice
53. 53.

    Alhnan M.A., Okwuosa T.C., Sadia M., Wan K.-W., Ahmed W., Arafat B. Emergence of 3D printed dosage forms: Opportunities and challenges. Pharm. Res. 2016;33:1817-1832.

    Not in our library10.1007/s11095-016-1933-1

54. 54.

    Melocchi A., Parietti F., Maroni A., Foppoli A., Gazzaniga A., Zema L. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling. Int. J. Pharm. 2016;509:255-263.

    Not in our library10.1016/j.ijpharm.2016.05.036

55. 55.

    Goyanes A., Martinez P.R., Buanz A., Basit A.W., Gaisford S. Effect of geometry on drug release from 3D printed tablets. Int. J. Pharm. 2015;494:657-663.

    Not in our library10.1016/j.ijpharm.2015.04.069

56. 56.

    Skowyra J., Pietrzak K., Alhnan M.A. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Eur. J. Pharm. Sci. 2015;68:11-17.

    Not in our library10.1016/j.ejps.2014.11.009

57. 57.

    Firth J., Basit A.W., Gaisford S. The role of semi-solid extrusion printing in clinical practice. 3D Printing of Pharmaceuticals. 2018;133-151.

    Not in our library

58. 58.
    3D Printing in Pharmaceutical and Medical Applications – Recent Achievements and Challenges · 2018

    No notice
59. 59.

    Ehtezazi T., Algellay M., Islam Y., Roberts M., Dempster N.M., Sarker S.D. The Application of 3D Printing in the Formulation of Multilayered Fast Dissolving Oral Films. J. Pharm. Sci. 2018;107:1076-1085.

    Not in our library10.1016/j.xphs.2017.11.019

60. 60.

    Zidan A., Alayoubi A., Coburn J., Asfari S., Ghammraoui B., Cruz C.N., Ashraf M. Extrudability analysis of drug loaded pastes for 3D printing of modified release tablets. Int. J. Pharm. 2019;554:292-301.

    Not in our library10.1016/j.ijpharm.2018.11.025

61. 61.

    Kollamaram G., Croker D.M., Walker G.M., Goyanes A., Basit A.W., Gaisford S. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs. Int. J. Pharm. 2018;545:144-152.

    Not in our library10.1016/j.ijpharm.2018.04.055

62. 62.

    Sadia M., Sośnicka A., Arafat B., Isreb A., Ahmed W., Kelarakis A., Alhnan M.A. Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. Int. J. Pharm. 2016;513:659-668.

    Not in our library10.1016/j.ijpharm.2016.09.050

63. 63.

    Tagami T., Ando M., Nagata N., Goto E., Yoshimura N., Takeuchi T., Noda T., Ozeki T.J.J. Fabrication of Naftopidil-Loaded Tablets Using a Semisolid Extrusion-Type 3D Printer and the Characteristics of the Printed Hydrogel and Resulting Tablets. J. Pharm. Sci. 2019;108:907-913.

    Not in our library10.1016/j.xphs.2018.08.026

64. 64.

    Capel A.J., Rimington R.P., Lewis M.P., Christie S.D. 3D printing for chemical, pharmaceutical and biological applications. Nat. Rev. Chem. 2018;2:422-436.

    Not in our library10.1038/s41570-018-0058-y

65. 65.

    Okwuosa T.C., Pereira B.C., Arafat B., Cieszynska M., Isreb A., Alhnan M.A. Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy. Pharm. Res. 2017;34:427-437.

    Not in our library10.1007/s11095-016-2073-3

66. 66.

    Azad M.A., Osorio J.G., Brancazio D., Hammersmith G., Klee D.M., Rapp K., Myerson A. A compact, portable, re-configurable, and automated system for on-demand pharmaceutical tablet manufacturing. Int. J. Pharm. 2018;539:157-164.

    Not in our library10.1016/j.ijpharm.2018.01.027

67. 67.

    Azad M.A., Osorio J.G., Wang A., Klee D.M., Eccles M.E., Grela E., Sloan R., Hammersmith G., Rapp K., Brancazio D., et al. On-Demand Manufacturing of Direct Compressible Tablets: Can Formulation Be Simplified? Pharm. Res. 2019;36:167.

    Not in our library10.1007/s11095-019-2716-2

68. 68.

    Maniruzzaman M. Pharmaceutical Applications of Hot-Melt Extrusion: Continuous Manufacturing, Twin-Screw Granulations, and 3D Printing. Pharmaceutics. 2019;11:218.

    Not in our library10.3390/pharmaceutics11050218

69. 69.
    Advanced Pharmaceutical Applications of Hot-Melt Extrusion Coupled with Fused Deposition Modelling (FDM) 3D Printing for Personalised Drug Delivery · 2018

    No notice
70. 70.

    Melocchi A., Parietti F., Loreti G., Maroni A., Gazzaniga A., Zema L. 3D printing by fused deposition modeling (FDM) of a swellable/erodible capsular device for oral pulsatile release of drugs. J. Drug Deliv. Sci. Technol. 2015;30:360-367.

    Not in our library10.1016/j.jddst.2015.07.016

71. 71.

    Zhang J., Feng X., Patil H., Tiwari R.V., Repka M.A. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Int. J. Pharm. 2017;519:186-197.

    Not in our library10.1016/j.ijpharm.2016.12.049

72. 72.

    Arafat B., Wojsz M., Isreb A., Forbes R.T., Isreb M., Ahmed W., Arafat T., Alhnan M.A. Tablet fragmentation without a disintegrant: A novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets. Eur. J. Pharm. Sci. 2018;118:191-199.

    Not in our library10.1016/j.ejps.2018.03.019

73. 73.

    Saviano M., Aquino R.P., Del Gaudio P., Sansone F., Russo P. Poly (vinyl alcohol) 3D printed tablets: The effect of polymer particle size on drug loading and process efficiency. Int. J. Pharm. 2019;561:1-8.

    Not in our library10.1016/j.ijpharm.2019.02.025

74. 74.

    Pereira B.C., Isreb A., Forbes R.T., Dores F., Habashy R., Petit J.-B., Alhnan M.A., Oga E.F. ‘Temporary Plasticiser’: A novel solution to fabricate 3D printed patient-centred cardiovascular ‘Polypill’architectures. Eur. J. Pharm. Biopharm. 2019;135:94-103.

    Not in our library10.1016/j.ejpb.2018.12.009

75. 75.

    Ilyés K., Balogh A., Casian T., Igricz T., Borbás E., Démuth B., Vass P., Menyhárt L., Kovács N.K., Marosi G. 3D Floating tablets: Appropriate 3d design from the perspective of different in vitro dissolution testing methodologies. Int. J. Pharm. 2019;567:118433.

    Not in our library10.1016/j.ijpharm.2019.06.024

76. 76.

    Khaled S.A., Burley J.C., Alexander M.R., Yang J., Roberts C.J. 3D printing of tablets containing multiple drugs with defined release profiles. In. J. Pharm. 2015;494:643-650.

    Not in our library10.1016/j.ijpharm.2015.07.067

77. 77.

    Conceição J., Farto-Vaamonde X., Goyanes A., Adeoye O., Concheiro A., Cabral-Marques H., Sousa Lobo J.M., Alvarez-Lorenzo C. Hydroxypropyl-β-cyclodextrin-based fast dissolving carbamazepine printlets prepared by semisolid extrusion 3D printing. Carbohydr. Polym. 2019;221:55-62.

    Not in our library10.1016/j.carbpol.2019.05.084

78. 78.

    Corporation T.L. Carbopol® Polymer Products.

    Not in our library

79. 79.

    Corporation T.L. Carbopol® 971P NF Polymer.

    Not in our library

80. 80.

    Corporation T.L. Carbopol® 974P NF Polymer.

    Not in our library

81. 81.

    Cellulosics D. ETHOCEL™: Ethylcellulose Polymers Technical Handbook. 2005;28.

    Not in our library

82. 82.

    Kempin W., Franz C., Koster L.-C., Schneider F., Bogdahn M., Weitschies W., Seidlitz A. Assessment of different polymers and drug loads for fused deposition modeling of drug loaded implants. Eur. J. Pharm. Biopharm. 2017;115:84-93.

    Not in our library10.1016/j.ejpb.2017.02.014

83. 83.

    Thakral S., Thakral N.K., Majumdar D.K. Eudragit®: A technology evaluation. Exp. Opin. Drug Deliv. 2013;10:131-149.

    Not in our library10.1517/17425247.2013.736962

84. 84.

    Evonik. Eudragit® Setting Benchmarks in Oral Solid Dosage Forms Since 1954.

    Not in our library

85. 85.

    Prasad L.K., Smyth H. 3D Printing technologies for drug delivery: A review. Drug Dev. Ind. Pharm. 2016;42:1019-1031.

    Not in our library10.3109/03639045.2015.1120743

86. 86.

    Picker-Freyer K.M., Dürig T. Physical mechanical and tablet formation properties of hydroxypropylcellulose: In pure form and in mixtures. AAPS PharmSciTech. 2007;8:82.

    Not in our library10.1208/pt0804092

87. 87.

    Ashland Inc. Klucel™ Hydroxypropylcellulose—Physical and Chemical Properties.

    Not in our library

88. 88.

    Li C.L., Martini L.G., Ford J.L., Roberts M. The use of hypromellose in oral drug delivery. J. Pharm. Pharmacol. 2005;57:533-546.

    Not in our library10.1211/0022357055957

89. 89.

    Siepmann J., Peppas N. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 2012;64:163-174.

    Not in our library10.1016/j.addr.2012.09.028

90. 90.

    Ethers M.C. Technical Handbook. 1997.

    Not in our library

91. 91.

    Gómez-Carracedo A., Alvarez-Lorenzo C., Gómez-Amoza J., Concheiro A. Chemical structure and glass transition temperature of non-ionic cellulose ethers. J. Therm. Anal. Calorim. 2003;73:587-596.

    Not in our library10.1023/a:1025434314396

92. 92.

    Patlolla A., Collins G., Arinzeh T.L. Solvent-dependent properties of electrospun fibrous composites for bone tissue regeneration. Acta Biomater. 2010;6:90-101.

    Not in our library10.1016/j.actbio.2009.07.028

93. 93.

    Goyanes A., Det-Amornrat U., Wang J., Basit A.W., Gaisford S. 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems. J. Control. Release. 2016;234:41-48.

    Not in our library10.1016/j.jconrel.2016.05.034

94. 94.

    Ulery B.D., Nair L.S., Laurencin C.T. Biomedical applications of biodegradable polymers. J. Polym. Sci. Part B. 2011;49:832-864.

    Not in our library10.1002/polb.22259

95. 95.

    Gunatillake P., Mayadunne R., Adhikari R. Recent developments in biodegradable synthetic polymers. Biotechnol. Annu. Rev. 2006;12:301-347.

    Not in our library10.1016/s1387-2656(06)12009-8

96. 96.

    Boetker J., Water J.J., Aho J., Arnfast L., Bohr A., Rantanen J. Modifying release characteristics from 3D printed drug-eluting products. Eur. J. Pharm. Sci. 2016;90:47-52.

    Not in our library10.1016/j.ejps.2016.03.013

97. 97.

    Dwivedi C., Pandey H., Pandey A.C., Patil S., Ramteke P.W., Laux P., Luch A., Singh A.V. In vivo biocompatibility of electrospun biodegradable dual carrier (antibiotic+ growth factor) in a mouse model—Implications for rapid wound healing. Pharmaceutics. 2019;11:180.

    Not in our library10.3390/pharmaceutics11040180

98. 98.

    Farah S., Anderson D.G., Langer R. Physical and mechanical properties of PLA, and their functions in widespread applications—A comprehensive review. Adv. Drug Deliv. Rev. 2016;107:367-392.

    Not in our library10.1016/j.addr.2016.06.012

99. 99.

    Fu J., Yin H., Yu X., Xie C., Jiang H., Jin Y., Sheng F. Combination of 3D printing technologies and compressed tablets for preparation of riboflavin floating tablet-in-device (TiD) systems. Int. J. Pharm. 2018;549:370-379.

    Not in our library10.1016/j.ijpharm.2018.08.011

100. 100.

     Goyanes A., Kobayashi M., Martínez-Pacheco R., Gaisford S., Basit A.W. Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets. Int. J. Pharm. 2016;514:290-295.

     Not in our library10.1016/j.ijpharm.2016.06.021

101. 101.

     Morita R., Honda R., Takahashi Y. Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS): I. Design of SCRS and its release controlling factor. J. Control. Release. 2000;63:297-304.

     Not in our library10.1016/s0168-3659(99)00203-5

102. 102.

     Gupta S., Webster T.J., Sinha A. Evolution of PVA gels prepared without crosslinking agents as a cell adhesive surface. J. Mater. Sci. Mater. Med. 2011;22:1763-1772.

     Not in our library10.1007/s10856-011-4343-2

103. 103.

     Matijašić G., Gretić M., Vinčić J., Poropat A., Cuculić L., Rahelić T. Design and 3D printing of multi-compartmental PVA capsules for drug delivery. J. Drug Deliv. Sci. 2019;52:677-686.

     Not in our library10.1016/j.jddst.2019.05.037

104. 104.

     Haaf F., Sanner A., Straub F. Polymers of N-vinylpyrrolidone: Synthesis, characterization and uses. Polym. J. 1985;17:143.

     Not in our library10.1295/polymj.17.143

105. 105.

     Sigma M. Poly(ethylene glycol) and Poly(ethylene oxide).

     Not in our library

106. 106.

     Pelras T., Glass S., Scherzer T., Elsner C., Schulze A., Abel B. Transparent low molecular weight poly (ethylene glycol) diacrylate-based hydrogels as film media for photoswitchable drugs. Polymers. 2017;9:639.

     Not in our library10.3390/polym9120639

107. 107.

     Hardung H., Djuric D., Ali S. Combining HME & solubilization: Soluplus®—The solid solution. Drug Deliv. Technol. 2010;10:20-27.

     Not in our library

108. 108.

     Goyanes A., Chang H., Sedough D., Hatton G.B., Wang J., Buanz A., Gaisford S., Basit A.W. Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing. Int. J. Pharm. 2015;496:414-420.

     Not in our library10.1016/j.ijpharm.2015.10.039

109. 109.

     Aho J., Boetker J.P., Baldursdottir S., Rantanen J. Rheology as a tool for evaluation of melt processability of innovative dosage forms. Int. J. Pharm. 2015;494:623-642.

     Not in our library10.1016/j.ijpharm.2015.02.009

110. 110.

     Yang Y., Wang H., Li H., Ou Z., Yang G. 3D printed tablets with internal scaffold structure using ethyl cellulose to achieve sustained ibuprofen release. Eur. J. Pharm. Sci. 2018;115:11-18.

     Not in our library10.1016/j.ejps.2018.01.005

111. 111.

     Baumgart F. Stiffness-an unknown world of mechanical science? Injury. 2000;31:14-23.

     Not in our library

112. 112.

     Okwuosa T.C., Stefaniak D., Arafat B., Isreb A., Wan K.-W., Alhnan M.A. A lower temperature FDM 3D printing for the manufacture of patient-specific immediate release tablets. Pharm. Res. 2016;33:2704-2712.

     Not in our library10.1007/s11095-016-1995-0

113. 113.

     Lewis J.A., Gratson G.M. Direct writing in three dimensions. Mater. Today. 2004;7:32-39.

     Not in our library10.1016/s1369-7021(04)00344-x

114. 114.

     Rattanakit P., Moulton S.E., Santiago K.S., Liawruangrath S., Wallace G.G. Extrusion printed polymer structures: A facile and versatile approach to tailored drug delivery platforms. Int. J. Pharm. 2012;422:254-263.

     Not in our library10.1016/j.ijpharm.2011.11.007

115. 115.

     Solanki N.G., Gumaste S.G., Shah A.V., Serajuddin A.T. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion. II: Rheological Analysis and Extrudability Testing. J. Pharm. Sci. 2019;108:3063-3073.

     Not in our library10.1016/j.xphs.2019.05.010

116. 116.
     Rheological and Mechanical Investigation into the Effect of Different Molecular Weight Poly(ethylene glycol)s on Polycaprolactone-Ciprofloxacin Filaments · 2019

     Not checked
117. 117.

     Polamaplly P., Cheng Y., Shi X., Manikandan K., Zhang X., Kremer G.E., Qin H. 3D printing and characterization of hydroxypropyl methylcellulose and methylcellulose for biodegradable support structures. Polymer. 2019;173:119-126.

     Not in our library10.1016/j.polymer.2019.04.013

118. 118.

     Suwardie H., Wang P., Todd D.B., Panchal V., Yang M., Gogos C.G. Rheological study of the mixture of acetaminophen and polyethylene oxide for hot-melt extrusion application. Eur. J. Pharm. 2011;78:506-512.

     Not in our library10.1016/j.ejpb.2011.03.013

119. 119.

     Rahim T.N.A.T., Abdullah A.M., Md Akil H. Recent Developments in Fused Deposition Modeling-Based 3D Printing of Polymers and Their Composites. Polym. Rev. 2019;59:589-624.

     Not in our library10.1080/15583724.2019.1597883

120. 120.

     Tanner R., Keentok M. Shear fracture in cone-plate rheometry. J. Rheol. 1983;27:47-57.

     Not in our library10.1122/1.549698

121. 121.

     Cox W., Merz E. Correlation of dynamic and steady flow viscosities. J. Polym. Sci. 1958;28:619-622.

     Not in our library10.1002/pol.1958.1202811812

122. 122.

     Cicala G., Giordano D., Tosto C., Filippone G., Recca A., Blanco I. Polylactide (PLA) filaments a biobased solution for additive manufacturing: Correlating rheology and thermomechanical properties with printing quality. Materials. 2018;11:1191.

     Not in our library10.3390/ma11071191

123. 123.

     Yang M., Wang P., Suwardie H., Gogos C. Determination of acetaminophen’s solubility in poly (ethylene oxide) by rheological, thermal and microscopic methods. Int. J. Pharm. 2011;403:83-89.

     Not in our library10.1016/j.ijpharm.2010.10.026

124. 124.

     Hu Y., Wang J., Li X., Hu X., Zhou W., Dong X., Wang C., Yang Z., Binks B.P. Facile preparation of bioactive nanoparticle/poly(ε-caprolactone) hierarchical porous scaffolds via 3D printing of high internal phase Pickering emulsions. J. Colloid Interface Sci. 2019;545:104-115.

     Not in our library10.1016/j.jcis.2019.03.024

125. 125.

     Kim M.H., Lee Y.W., Jung W.-K., Oh J., Nam S.Y. Enhanced rheological behaviors of alginate hydrogels with carrageenan for extrusion-based bioprinting. J. Mech. Behav. Biomed. Mater. 2019;98:187-194.

     Not in our library10.1016/j.jmbbm.2019.06.014

126. 126.

     Ibrahim M., Barnes M., McMillin R., Cook D.W., Smith S., Halquist M., Wijesinghe D., Roper T.D. 3D Printing of Metformin HCl PVA Tablets by Fused Deposition Modeling: Drug Loading, Tablet Design, and Dissolution Studies. AAPS PharmSciTech. 2019;20:195.

     Not in our library10.1208/s12249-019-1400-5

127. 127.

     Tagami T., Fukushige K., Ogawa E., Hayashi N., Ozeki T. 3D printing factors important for the fabrication of polyvinylalcohol filament-based tablets. Biol. Pharm. Bull. 2017;40:357-364.

     Not in our library10.1248/bpb.b16-00878

128. 128.

     Prasad E., Islam M.T., Goodwin D.J., Megarry A.J., Halbert G.W., Florence A.J., Robertson J. Development of a hot-melt extrusion (HME) process to produce drug loaded Affinisol™ 15LV filaments for fused filament fabrication (FFF) 3D printing. Addit. Manuf. 2019;29:100776.

     Not in our library10.1016/j.addma.2019.06.027

129. 129.

     Öblom H., Zhang J., Pimparade M., Speer I., Preis M., Repka M., Sandler N. 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis—Personalized Dosing and Drug Release. AAPS PharmSciTech. 2019;20:52.

     Not in our library10.1208/s12249-018-1233-7

130. 130.

     Verstraete G., Samaro A., Grymonpré W., Vanhoorne V., Van Snick B., Boone M., Hellemans T., Van Hoorebeke L., Remon J.P., Vervaet C. 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes. Int. J. Pharm. 2018;536:318-325.

     Not in our library10.1016/j.ijpharm.2017.12.002

131. 131.

     Goyanes A., Fina F., Martorana A., Sedough D., Gaisford S., Basit A.W. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing. Int. J. Pharm. 2017;527:21-30.

     Not in our library10.1016/j.ijpharm.2017.05.021

132. 132.

     Sadia M., Isreb A., Abbadi I., Isreb M., Aziz D., Selo A., Timmins P., Alhnan M.A. From ‘fixed dose combinations’ to ‘a dynamic dose combiner’: 3D printed bi-layer antihypertensive tablets. Eur. J. Pharm. Sci. 2018;123:484-494.

     Not in our library10.1016/j.ejps.2018.07.045

133. 133.
     Material Considerations for Fused-Filament Fabrication of Solid Dosage Forms · 2018

     Not checked
134. 134.

     Aho J., Genina N., Edinger M., Botker J.P., Baldursdottir S., Rantanen J. Drug-loaded poly (ε-caprolactone) for 3D printing of personalized medicine: A rheological study. Proceedings of the 25th Nordic Rheology Conference. 97-100.

     Not in our library

135. 135.

     Isreb A., Baj K., Wojsz M., Isreb M., Peak M., Alhnan M.A. 3D printed oral theophylline doses with innovative ‘radiator-like’design: Impact of polyethylene oxide (PEO) molecular weight. Int. J. Pharm. 2019;564:98-105.

     Not in our library10.1016/j.ijpharm.2019.04.017

136. 136.

     Ilyés K., Kovács N.K., Balogh A., Borbás E., Farkas B., Casian T., Marosi G., Tomuță I., Nagy Z.K. The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations–printability–process modulation, with consecutive effects on in vitro release, stability and degradation. Eur. J. Pharm. Sci. 2019;129:110-123.

     Not in our library10.1016/j.ejps.2018.12.019

137. 137.

     Solanki N.G., Tahsin M., Shah A.V., Serajuddin A.T. Formulation of 3D printed tablet for rapid drug release by fused deposition modeling: Screening polymers for drug release, drug-polymer miscibility and printability. J. Pharm. Sci. 2018;107:390-401.

     Not in our library10.1016/j.xphs.2017.10.021

138. 138.

     Aho J., Van Renterghem J., Arnfast L., De Beer T., Rantanen J. The flow properties and presence of crystals in drug-polymer mixtures: Rheological investigation combined with light microscopy. Int. J. Pharm. 2017;528:383-394.

     Not in our library10.1016/j.ijpharm.2017.06.012

139. 139.

     Zidan A., Alayoubi A., Asfari S., Coburn J., Ghammraoui B., Aqueel S., Cruz C.N., Ashraf M. Development of mechanistic models to identify critical formulation and process variables of pastes for 3D printing of modified release tablets. Int. J. Pharm. 2019;555:109-123.

     Not in our library10.1016/j.ijpharm.2018.11.044

140. 140.

     Van Renterghem J., Vervaet C., De Beer T. Rheological characterization of molten polymer-drug dispersions as a predictive tool for pharmaceutical hot-melt extrusion processability. Pharm. Res. 2017;34:2312-2321.

     Not in our library10.1007/s11095-017-2239-7

141. 141.

     Gupta S.S., Solanki N., Serajuddin A.T. Investigation of thermal and viscoelastic properties of polymers relevant to hot melt extrusion, IV: Affinisol™ HPMC HME polymers. AAPS PharmSciTech. 2016;17:148-157.

     Not in our library10.1208/s12249-015-0426-6

142. 142.

     Goyanes A., Allahham N., Trenfield S.J., Stoyanov E., Gaisford S., Basit A.W. Direct powder extrusion 3D printing: Fabrication of drug products using a novel single-step process. Int. J. Pharm. 2019;567:118471.

     Not in our library10.1016/j.ijpharm.2019.118471

143. 143.

     Genina N., Boetker J.P., Colombo S., Harmankaya N., Rantanen J., Bohr A. Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing. J. Control. Release. 2017;268:40-48.

     Not in our library10.1016/j.jconrel.2017.10.003

144. 144.

     Smith D., Kapoor Y., Hermans A., Nofsinger R., Kesisoglou F., Gustafson T.P., Procopio A. 3D printed capsules for quantitative regional absorption studies in the GI tract. Int. J. Pharm. 2018;550:418-428.

     Not in our library10.1016/j.ijpharm.2018.08.055

145. 145.

     Huanbutta K., Sangnim T. Design and development of zero-order drug release gastroretentive floating tablets fabricated by 3D printing technology. J. Drug Deliv. Sci. Technol. 2019;52:831-837.

     Not in our library10.1016/j.jddst.2019.06.004

146. 146.

     Kadry H., Al-Hilal T.A., Keshavarz A., Alam F., Xu C., Joy A., Ahsan F. Multi-purposable filaments of HPMC for 3D printing of medications with tailored drug release and timed-absorption. Int. J. Pharm. 2018;544:285-296.

     Not in our library10.1016/j.ijpharm.2018.04.010

147. 147.

     Tagami T., Hayashi N., Sakai N., Ozeki T. 3D printing of unique water-soluble polymer-based suppository shell for controlled drug release. Int. J. Pharm. 2019;568:118494.

     Not in our library10.1016/j.ijpharm.2019.118494

148. 148.

     El Aita I., Breitkreutz J., Quodbach J. On-demand manufacturing of immediate release levetiracetam tablets using pressure-assisted microsyringe printing. Eur. J. Pharm. Biopharm. 2019;134:29-36.

     Not in our library10.1016/j.ejpb.2018.11.008

149. 149.

     Khaled S.A., Alexander M.R., Wildman R.D., Wallace M.J., Sharpe S., Yoo J., Roberts C.J. 3D extrusion printing of high drug loading immediate release paracetamol tablets. Int. J. Pharm. 2018;538:223-230.

     Not in our library10.1016/j.ijpharm.2018.01.024

150. 150.

     Li Q., Guan X., Cui M., Zhu Z., Chen K., Wen H., Jia D., Hou J., Xu W., Yang X., et al. Preparation and investigation of novel gastro-floating tablets with 3D extrusion-based printing. Int. J. Pharm. 2018;535:325-332.

     Not in our library10.1016/j.ijpharm.2017.10.037

151. 151.

     Li P., Zhang S., Sun W., Cui M., Wen H., Li Q., Pan W., Yang X. Flexibility of 3D Extruded Printing for a Novel Controlled-Release Puerarin Gastric Floating Tablet: Design of Internal Structure. AAPS PharmSciTech. 2019;20:1-13.

     Not in our library10.1208/s12249-019-1455-3

152. 152.

     Siyawamwaya M., du Toit L.C., Kumar P., Choonara Y.E., Kondiah P., Pillay V. 3D printed, controlled release, tritherapeutic tablet matrix for advanced anti-HIV-1 drug delivery. Eur. J. Pharm. Biopharm. 2019;138:99-110.

     Not in our library10.1016/j.ejpb.2018.04.007

153. 153.

     Heidemann H.M., Laurindo J.B., Carciofi B.A.M., Costa C., Dotto M.E.R. Cold plasma treatment to improve the adhesion of cassava starch films onto PCL and PLA surface. Colloids Surfaces A. 2019;580:123739.

     Not in our library10.1016/j.colsurfa.2019.123739

154. 154.

     Azman Mohammad Taib M.N., Julkapli N.M., Jawaid M., Thariq M., Saba N. 4-Dimensional stability of natural fiber-based and hybrid composites. Mechanical and Physical Testing of Biocomposites, Fibre-Reinforced Composites and Hybrid Composites. 2019;61-79.

     Not in our library

155. 155.

     Awaja F., Gilbert M., Kelly G., Fox B., Pigram P.J. Adhesion of polymers. Prog. Polym. Sci. 2009;34:948-968.

     Not in our library10.1016/j.progpolymsci.2009.04.007

156. 156.

     Messimer S.L., Patterson A.E., Muna N., Deshpande A.P., Rocha Pereira T. Characterization and Processing Behavior of Heated Aluminum-Polycarbonate Composite Build Plates for the FDM Additive Manufacturing Process. J. Manuf. Mater. Process. 2018;2:12.

     Not in our library10.3390/jmmp2010012

157. 157.

     Ortega-Toro R., Santagata G., Gomez d’Ayala G., Cerruti P., Talens Oliag P., Chiralt Boix M.A., Malinconico M. Enhancement of interfacial adhesion between starch and grafted poly(ε-caprolactone). Carbohydr. Polym. 2016;147:16-27.

     Not in our library10.1016/j.carbpol.2016.03.070

158. 158.

     Gioumouxouzis C.I., Baklavaridis A., Katsamenis O.L., Markopoulou C.K., Bouropoulos N., Tzetzis D., Fatouros D.G. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery. Eur. J. Pharm. Sci. 2018;120:40-52.

     Not in our library10.1016/j.ejps.2018.04.020

159. 159.

     Vakili H., Kolakovic R., Genina N., Marmion M., Salo H., Ihalainen P., Peltonen J., Sandler N. Hyperspectral imaging in quality control of inkjet printed personalised dosage forms. Int. J. Pharm. 2015;483:244-249.

     Not in our library10.1016/j.ijpharm.2014.12.034

160. 160.

     Alomari M., Mohamed F.H., Basit A.W., Gaisford S. Personalised dosing: Printing a dose of one’s own medicine. Int. J. Pharm. 2015;494:568-577.

     Not in our library10.1016/j.ijpharm.2014.12.006

161. 161.

     Cheah C., Leong K., Chua C., Low K., Quek H. Characterization of microfeatures in selective laser sintered drug delivery devices. Proc. Inst. Mech. Eng. Part H J. Eng. Med. 2002;216:369-383.

     Not in our library10.1243/095441102321032166

162. 162.

     Amza C., Zapciu A., Popescu D. Paste Extruder—Hardware Add-On for Desktop 3D Printers. Technologies. 2017;5:50.

     Not in our library10.3390/technologies5030050

163. 163.

     Neches R.Y., Flynn K.J., Zaman L., Tung E., Pudlo N. On the intrinsic sterility of 3D printing. PeerJ. 2016;4:e2661.

     Not in our library10.7717/peerj.2661

164. 164.

     Campbell R. Pharma to table: 3-D printing and the regulatory future of home remedies. Conn. L. Rev. CONNtemplations. 2017;49:1.

     Not in our library

165. 165.

     Zhang J., Yang W., Vo A.Q., Feng X., Ye X., Kim D.W., Repka M.A. Hydroxypropyl methylcellulose-based controlled release dosage by melt extrusion and 3D printing: Structure and drug release correlation. Carbohydr. Polym. 2017;177:49-57.

     Not in our library10.1016/j.carbpol.2017.08.058

166. 166.

     Cheng K., Zhu J., Song X., Sun L., Zhang J. Studies of Hydroxypropyl Methylcellulose Donut-Shaped Tablets. Drug Dev. Ind. Pharm. 1999;25:1067.

     Not in our library10.1081/ddc-100102271

167. 167.

     Lim S.H., Kathuria H., Tan J.J.Y., Kang L. (2018). 3D printed drug delivery and testing systems—A passing fad or the future. Adv. Drug Delivery Rev. 2018;132:139-168.

     Not in our library10.1016/j.addr.2018.05.006

168. 168.

     Food U., Administration D. Facts about the Current Good Manufacturing Practices (CGMPs).

     Not in our library

169. 169.

     Melocchi A., Parietti F., Maccagnan S., Ortenzi M.A., Antenucci S., Briatico-Vangosa F., Maroni A., Gazzaniga A., Zema L. Industrial Development of a 3D-Printed Nutraceutical Delivery Platform in the Form of a Multicompartment HPC Capsule. AAPS PharmSciTech. 2018;19:3343-3354.

     Not in our library10.1208/s12249-018-1029-9

170. 170.

     Sanderson K. 3D printing: The future of manufacturing medicine. Pharm. J. 2015;294:598-600.

     Not in our library

171. 171.

     FDA. Are You Taking Medication as Prescribed?

     Not in our library

172. 172.

     Florence A.T., Lee V.H. Personalised medicines: More tailored drugs, more tailored delivery. Int. J. Pharm. 2011;415:29-33.

     Not in our library10.1016/j.ijpharm.2011.04.047

173. 173.

     Schiele J.T., Quinzler R., Klimm H.-D., Pruszydlo M.G., Haefeli W.E. Difficulties swallowing solid oral dosage forms in a general practice population: Prevalence, causes, and relationship to dosage forms. Eur. J. Clinical Pharmacol. 2013;69:937-948.

     Not in our library10.1007/s00228-012-1417-0

174. 174.

     Spence J.D. Polypill: For Pollyanna. Int. J. Stroke. 2008;3:92-97.

     Not in our library10.1111/j.1747-4949.2008.00169.x

175. 175.

     Pharmaceuticals C. About PolycapTM.

     Not in our library

176. 176.

     Urquhart J. The indian polycap study (TIPS). Lancet. 2009;374:781-782.

     Not in our library10.1016/s0140-6736(09)61586-5

177. 177.

     Wu W., Zheng Q., Guo X., Sun J., Liu Y. A programmed release multi-drug implant fabricated by three-dimensional printing technology for bone tuberculosis therapy. Biomed. Mater. 2009;4:065005.

     Not in our library10.1088/1748-6041/4/6/065005

178. 178.

     Acosta-Vélez G., Linsley C., Zhu T., Wu W., Wu B. Photocurable Bioinks for the 3D Pharming of Combination Therapies. Polymers. 2018;10:1372.

     Not in our library10.3390/polym10121372

179. 179.

     Haring A.P., Tong Y., Halper J., Johnson B.N. Programming of multicomponent temporal release profiles in 3D printed polypills via core–shell, multilayer, and gradient concentration profiles. Adv. Healthc. Mater. 2018;7:1800213.

     Not in our library10.1002/adhm.201800213

180. 180.

     Fastø M.M., Genina N., Kaae S., Sporrong S.K. Perceptions, preferences and acceptability of patient designed 3D printed medicine by polypharmacy patients: A pilot study. Int. J. Clin. Pharm. 2019;41:1290-1298.

     Not in our library10.1007/s11096-019-00892-6

181. 181.
     3D Printing of a Multi-Layered Polypill Containing Six Drugs Using a Novel Stereolithographic Method · 2019

     No notice
182. 182.

     Goyanes A., Wang J., Buanz A., Martínez-Pacheco R., Telford R., Gaisford S., Basit A.W. 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics. Mol. Pharm. 2015;12:4077-4084.

     Not in our library10.1021/acs.molpharmaceut.5b00510

Cited by papers we hold 2

• 3D-printed drug delivery system from food waste: A sustainable approach for the development of novel drug delivery systems · 2025
  Not checked
• 3D Printing as a Promising Tool in Personalized Medicine · 2021
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.